EP1139754A4 - 3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATION OF PROTEIN KINASE ACTIVITY AND IN CANCER CHEMOTHERAPY - Google Patents
3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATION OF PROTEIN KINASE ACTIVITY AND IN CANCER CHEMOTHERAPYInfo
- Publication number
- EP1139754A4 EP1139754A4 EP99966725A EP99966725A EP1139754A4 EP 1139754 A4 EP1139754 A4 EP 1139754A4 EP 99966725 A EP99966725 A EP 99966725A EP 99966725 A EP99966725 A EP 99966725A EP 1139754 A4 EP1139754 A4 EP 1139754A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- heteroarylidenyl
- protein kinase
- kinase activity
- cancer chemotherapy
- modulating protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11431398P | 1998-12-31 | 1998-12-31 | |
US114313P | 1998-12-31 | ||
PCT/US1999/031232 WO2000038519A1 (en) | 1998-12-31 | 1999-12-30 | 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1139754A1 EP1139754A1 (en) | 2001-10-10 |
EP1139754A4 true EP1139754A4 (en) | 2002-12-18 |
Family
ID=22354480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99966725A Withdrawn EP1139754A4 (en) | 1998-12-31 | 1999-12-30 | 3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATION OF PROTEIN KINASE ACTIVITY AND IN CANCER CHEMOTHERAPY |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1139754A4 (ja) |
JP (1) | JP2002533360A (ja) |
KR (1) | KR20010108063A (ja) |
CN (1) | CN1356872A (ja) |
AU (1) | AU760964B2 (ja) |
BR (1) | BR9916735A (ja) |
CA (1) | CA2357042A1 (ja) |
IL (1) | IL143920A0 (ja) |
MX (1) | MXPA01006742A (ja) |
WO (1) | WO2000038519A1 (ja) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6569868B2 (en) | 1998-04-16 | 2003-05-27 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
US6878733B1 (en) | 1999-11-24 | 2005-04-12 | Sugen, Inc. | Formulations for pharmaceutical agents ionizable as free acids or free bases |
WO2001037820A2 (en) * | 1999-11-24 | 2001-05-31 | Sugen, Inc. | Ionizable indolinone derivatives and their use as ptk ligands |
CZ303705B6 (cs) * | 2000-02-15 | 2013-03-27 | Sugen, Inc. | Pyrrolem substituovaná 2-indolinonová sloucenina pro pouzití jako inhibitor proteinkináz a farmaceutická kompozice s jejím obsahem |
NZ520593A (en) * | 2000-02-28 | 2004-10-29 | Aventis Pharma S | A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
MY128450A (en) | 2000-05-24 | 2007-02-28 | Upjohn Co | 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
US6706709B2 (en) | 2000-06-02 | 2004-03-16 | Sugen, Inc. | Indolinone derivatives as protein kinase/phosphatase inhibitors |
BRPI0207961B8 (pt) | 2001-03-14 | 2021-05-25 | Bristol Myers Squibb Co | uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. |
US6599902B2 (en) | 2001-05-30 | 2003-07-29 | Sugen, Inc. | 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors |
AR038957A1 (es) * | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
WO2003035614A2 (en) * | 2001-10-25 | 2003-05-01 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
WO2003035616A2 (en) * | 2001-10-25 | 2003-05-01 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
WO2003035619A1 (en) * | 2001-10-25 | 2003-05-01 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
WO2003045307A2 (en) * | 2001-11-21 | 2003-06-05 | Sugen, Inc. | Pharmaceutical formulations comprising indolinone derivatives |
US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
US6797825B2 (en) | 2001-12-13 | 2004-09-28 | Abbott Laboratories | Protein kinase inhibitors |
AU2002360753B2 (en) | 2001-12-27 | 2008-08-21 | Theravance, Inc. | Indolinone derivatives useful as protein kinase inhibitors |
CN1662234A (zh) | 2002-06-25 | 2005-08-31 | 惠氏公司 | 硫代-羟吲哚衍生物在治疗与激素有关的病症中的用途 |
EP1515680A4 (en) | 2002-06-25 | 2005-09-21 | Wyeth Corp | USE OF THIO-OXINDOLE DERIVATIVES IN THE TREATMENT OF SKIN DISORDERS |
KR101036866B1 (ko) | 2002-08-02 | 2011-05-25 | 에이비 사이언스 | 2-(3-아미노아릴)아미노-4-아릴-티아졸 및 c-kit억제제로서의 이의 용도 |
US8450302B2 (en) | 2002-08-02 | 2013-05-28 | Ab Science | 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
WO2004045617A1 (en) * | 2002-11-15 | 2004-06-03 | Warner-Lambert Company Llc | Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer |
CA2542909C (en) | 2003-10-23 | 2012-07-10 | Ab Science | 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
CN100432071C (zh) * | 2004-11-05 | 2008-11-12 | 中国科学院上海药物研究所 | 取代1h-吲哚-2-酮类化合物及其制备方法和用途 |
UA95071C2 (ru) | 2005-04-04 | 2011-07-11 | Аб Сьянс | Замещенные производные оксазола и их применение как ингибиторов тирозинкиназы |
US8246966B2 (en) | 2006-08-07 | 2012-08-21 | University Of Georgia Research Foundation, Inc. | Trypanosome microsome system and uses thereof |
CA2669531A1 (en) | 2006-11-22 | 2008-06-05 | University Of Georgia Research Foundation, Inc. | Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents |
HUE037928T2 (hu) * | 2011-11-11 | 2018-09-28 | Lilly Co Eli | Kombinációs terápia petefészekrák ellen |
US11083755B2 (en) | 2015-01-08 | 2021-08-10 | The Board Of Trustees Of The Leland Stanford Junior University | Factors and cells that provide for induction of bone, bone marrow, and cartilage |
SI3288940T1 (sl) | 2015-04-29 | 2021-07-30 | Janssen Pharmaceutica Nv | Azabenzimidazoli in njihova uporaba kot modulatorji AMPA-receptorja |
CN105585558A (zh) * | 2015-12-15 | 2016-05-18 | 贵州大学 | 双烷氧基嘧啶拼接3-烯键氧化吲哚衍生物及其制备方法及应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007695A1 (en) * | 1996-08-23 | 1998-02-26 | Sugen, Inc. | Indolinone combinatorial libraries and related products and methods for the treatment of disease |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
-
1999
- 1999-12-30 IL IL14392099A patent/IL143920A0/xx unknown
- 1999-12-30 WO PCT/US1999/031232 patent/WO2000038519A1/en not_active Application Discontinuation
- 1999-12-30 EP EP99966725A patent/EP1139754A4/en not_active Withdrawn
- 1999-12-30 MX MXPA01006742A patent/MXPA01006742A/es unknown
- 1999-12-30 JP JP2000590484A patent/JP2002533360A/ja not_active Withdrawn
- 1999-12-30 KR KR1020017008453A patent/KR20010108063A/ko not_active Application Discontinuation
- 1999-12-30 CA CA002357042A patent/CA2357042A1/en not_active Abandoned
- 1999-12-30 BR BR9916735-2A patent/BR9916735A/pt not_active IP Right Cessation
- 1999-12-30 AU AU22215/00A patent/AU760964B2/en not_active Ceased
- 1999-12-30 CN CN99816376A patent/CN1356872A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007695A1 (en) * | 1996-08-23 | 1998-02-26 | Sugen, Inc. | Indolinone combinatorial libraries and related products and methods for the treatment of disease |
Also Published As
Publication number | Publication date |
---|---|
MXPA01006742A (es) | 2004-04-21 |
JP2002533360A (ja) | 2002-10-08 |
WO2000038519A1 (en) | 2000-07-06 |
AU2221500A (en) | 2000-07-31 |
BR9916735A (pt) | 2001-09-25 |
KR20010108063A (ko) | 2001-12-07 |
AU760964B2 (en) | 2003-05-22 |
IL143920A0 (en) | 2002-04-21 |
CA2357042A1 (en) | 2000-07-06 |
CN1356872A (zh) | 2002-07-03 |
EP1139754A1 (en) | 2001-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1139754A4 (en) | 3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATION OF PROTEIN KINASE ACTIVITY AND IN CANCER CHEMOTHERAPY | |
IL146094A0 (en) | Diaminothiazoles and their use for inhibiting protein kinases | |
HUP0200403A2 (en) | Pyrrolopyrimidines as protein kinase inhibitors, pharmaceutical compositions containing them and their use | |
EP1066286A4 (en) | PROTEIN TYROSINE KINASE INHIBITORS, BASED ON IMIDAZOPYRAZINE WITH HETEROCYCLO SUBSTITUTION | |
IL193615A0 (en) | New azaindoles for inhibiting protein kinases and pharmaceutical composition comprising the same | |
ZA989249B (en) | Heteroaromatic compounds and their use in medicine. | |
ZA98166B (en) | Quinoline and quinazoline compounds useful in therapy | |
GB2337200B (en) | Smoking substance for use in therapy | |
EP1005480A4 (en) | KINASES OF HUMAN PROTEINKINASE ACTIVATED BY CYTOKINE, STRESS AND ONCOPROTEINE | |
IL114418A0 (en) | Tumor necrosis factor receptor-II associated protein kinase and methods for its use | |
IL206604A0 (en) | Transmembrane protein expressed in prostate cancer | |
EP1112354A4 (en) | NOVEL PROTEIN KINASE MOLECULES AND THEIR USES | |
HUP0103079A2 (hu) | Vegyes eredetű kinázproteinek aktivitásának módosítása | |
GB9816761D0 (en) | Herpesvirus preparations and their uses | |
ZA985999B (en) | Protein kinases and uses thereof | |
AU4686299A (en) | Nek-related and bub1-related protein kinases | |
AU1456899A (en) | Human protein kinase and kinase inhibitors | |
IL147345A0 (en) | Drosphila recombination- associated protein and methods for use | |
AU6111800A (en) | 26 human prostate and prostate cancer associated proteins | |
GB9703633D0 (en) | Cancer therapy | |
GB9803399D0 (en) | Protein kinase c | |
IL142273A0 (en) | Testis specific proteins expressed in prostate cancer | |
AU4328399A (en) | Nucleic acid-cobalamin complexes and their use in gene therapy | |
GB9613629D0 (en) | Reg gene expression in cancer tissue | |
ZA987206B (en) | Cycline-dependent protein kinase-activating kinase and its uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010730 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SUN, LI Inventor name: TANG, PENG, CHO Inventor name: SHAWVER, LAURA, KAY Inventor name: LANGECKER, PETER, J. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20021107 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 01N 43/38 A, 7A 61K 31/40 B, 7A 61K 31/505 B |
|
17Q | First examination report despatched |
Effective date: 20030915 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040126 |